BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17303177)

  • 21. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
    Takai N; Kawamata N; Walsh CS; Gery S; Desmond JC; Whittaker S; Said JW; Popoviciu LM; Jones PA; Miyakawa I; Koeffler HP
    Mol Cancer Res; 2005 May; 3(5):261-9. PubMed ID: 15886297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
    Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M
    Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and enrichment of human genomic CpG islands by methylation-sensitive mirror orientation selection.
    Huang Q; Baum L; Huang JF; You JP; Wang F; Wang J; Zheng J; Yan XC; Xia H; Zhao YH; Kuang H; Fu WL
    Anal Biochem; 2007 Jun; 365(2):153-64. PubMed ID: 17481566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.
    Ulazzi L; Sabbioni S; Miotto E; Veronese A; Angusti A; Gafà R; Manfredini S; Farinati F; Sasaki T; Lanza G; Negrini M
    Mol Cancer; 2007 Feb; 6():17. PubMed ID: 17328794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
    Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
    Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.
    Ikeda JI; Morii E; Kimura H; Tomita Y; Takakuwa T; Hasegawa JI; Kim YK; Miyoshi Y; Noguchi S; Nishida T; Aozasa K
    J Pathol; 2006 Sep; 210(1):75-84. PubMed ID: 16823897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
    Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
    Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers.
    Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T
    Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression and methylation status of 14-3-3sigma in human renal carcinoma tissues.
    Liang S; Xu Y; Shen G; Zhao X; Zhou J; Li X; Gong F; Ling B; Fang L; Huang C; Wei Y
    IUBMB Life; 2008 Aug; 60(8):534-40. PubMed ID: 18548556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
    Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
    Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells.
    Bhatia K; Siraj AK; Hussain A; Bu R; Gutiérrez MI
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):165-9. PubMed ID: 12582028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does aberrant DNA methylation occur in human uterine leiomyomas? An attempt of genome-wide screening by MS-RDA.
    Cai LY; Izumi S; Abe M; Imura M; Yasugi T; Wakazono K; Ohnuki Y; Kondo A; Ushijima T
    Tokai J Exp Clin Med; 2011 Sep; 36(3):84-90. PubMed ID: 21932190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
    Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
    Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.